A report from Hainan International Media Center: On the evening of Dec. 9th, the 7th Hainan Island International Film Festival (HIIFF) concluded. This thrilling event was held just prior to the imminent start of island-wide special customs operations in the Hainan Free Trade Port, showcasing the island's many charms through film screenings, industry collaborations, and […]

Physical goods orders increased by 30% year-over-year for the Two Months Ended November 30, 2025 Physical goods GMV increased by 35% year-over-year for the Two Months Ended November 30, 2025; excluding corporate sales, physical goods GMV grew 41% year-over-year Nigeria continued to perform strongly for the Two Months Ended November 30, 2025, with physical goods

ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk GlobeNewswire December 10, 2025 Results support the potential of PMN310 to improve outcomes by selectively targeting oligomers and avoiding binding to monomer and plaque ProMIS on track to complete enrollment in PRECISE-AD trial in Alzheimer's

Voyageur and Evolve Royalties Receive Conditional Approval for Proposed Reverse Take-Over and Listing on the CSE and Announce Board of Directors GlobeNewswire December 10, 2025 Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States. TORONTO,

Medicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors GlobeNewswire December 10, 2025 MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS endometrial cancer, MSI-H and TMB-H cancers, in each case exceeding objective response rate (ORR)

Daktronics, Inc. Announces 2026 Fiscal Second Quarter Results GlobeNewswire December 10, 2025 Operating Profit of $22 million, up 36.7% YoY, Operating Margin of 9.4% Double-digit growth in orders and sales Entering Second Half with $321 million of Product Backlog, up 36% from second quarter fiscal 2025 Ending Net Cash Balance of $138 million Business and

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS(R) 2025 GlobeNewswire December 10, 2025 BriaCell presents positive clinical data in three posters at the San Antonio Breast Cancer Symposium (SABCS(R)) Phase 3 study of Bria-IMT(TM) plus immune check point inhibitor (CPI) continues to support biomarkers to identify patients who benefit

Vertero Establishes Scientific Advisory Board to Advance Innovation in Neurodegenerative Diseases Renowned global leaders will guide scientific strategy in Parkinson's disease and beyond as company enters clinical development GlobeNewswire December 10, 2025 WOBURN, Mass., Dec. 10, 2025 (GLOBE NEWSWIRE) — Vertero Therapeutics, a clinical-stage biotechnology company breaking barriers in neurodegenerative disease treatment, today announced the

Avance Clinical Launches Diversity in STEM Scholarships Across Australia and North America GlobeNewswire December 10, 2025 ADELAIDE, Australia, Dec. 10, 2025 (GLOBE NEWSWIRE) — Avance Clinical, the award-winning global CRO for biotechs, has announced the launch of its new Diversity in STEM Scholarships, a global initiative designed to support women and minority-group students pursuing careers

Bread Financial Provides Performance Update for November 2025 GlobeNewswire December 10, 2025 COLUMBUS, Ohio, Dec. 10, 2025 (GLOBE NEWSWIRE) — Bread Financial Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending, and saving solutions to millions of U.S. consumers, provided a performance update. The following tables present the Company's